Waxman Irving, Dye Charles E
Section of Endoscopy and Therapeutics, University of Chicago, Illinois 60637, USA.
Cancer J. 2002 May-Jun;8 Suppl 1:S113-23.
Endoscopic ultrasound (EUS) has become the most accurate imaging modality for locoregional cancer staging of the gastrointestinal (GI) tract. Fine-needle aspiration (FNA) capabilities have added a whole new level of accuracy in nodal staging with reported numbers in the 90% range for luminal and pancreaticobiliary disease. In addition, new non-GI applications are being evaluated like the role of EUS-FNA for non-small cell lung carcinoma and exploration of the posterior mediastinum. Furthermore, the same capabilities that allow for safe tissue sampling are being explored for interventional applications like EUS-guided celiac plexus neurolysis and fine-needle injection. The following review describes the current clinical status of EUS in GI oncology as well as future and novel indications and therapeutic strategies for this technology.
内镜超声（EUS）已成为胃肠道（GI）局部区域癌症分期最准确的成像方式。细针穿刺抽吸（FNA）功能在淋巴结分期方面提高了全新的准确性水平，腔内和胰胆疾病的报告准确率在90%左右。此外，正在评估EUS-FNA在非小细胞肺癌中的作用以及后纵隔探查等新的非胃肠道应用。此外，还在探索将允许安全组织采样的相同功能用于介入应用，如EUS引导的腹腔神经丛神经溶解术和细针注射。以下综述描述了EUS在胃肠肿瘤学中的当前临床状况以及该技术未来的新适应症和治疗策略。
